Albemarle Completes Sale of Controlling Stake in Ketjen to KPS Capital Partners
Get Alerts ALB Hot Sheet
Join SI Premium – FREE
Albemarle retains a minority stake in Ketjen, with KPS having a majority of the Board of Directors and operational control. Albemarle retains 100% ownership of Ketjen's Performance Catalyst Solutions business, which has been integrated into Albemarle's product portfolio.
Combined with the sale of its 50% interest in the Eurecat joint venture to Axens SA, which was completed in
"Our continued investment in Ketjen alongside KPS demonstrates our confidence in the company's growth and value-creation potential," said
Goldman Sachs & Co. LLC acted as exclusive financial advisor, and K&L Gates LLP served as legal advisor to Albemarle for the transaction.
About Albemarle
Albemarle Corporation (NYSE: ALB) leads the world in transforming essential resources into critical ingredients for mobility, energy, connectivity and health. We partner to pioneer new ways to move, power, connect and protect with people and planet in mind. A reliable and high-quality global supply of lithium and bromine allows us to deliver advanced solutions for our customers. Learn more about how the people of Albemarle are enabling a more resilient world at Albemarle.com.
Albemarle regularly posts information to Albemarle.com, including notification of events, news, financial performance, investor presentations and webcasts, non-GAAP reconciliations, U.S. Securities and Exchange Commission filings and other information regarding the company, its businesses and the markets it serves.
About KPS Capital Partners
KPS, through its affiliated management entities, is the manager of the KPS Special Situations Funds, a family of investment funds with approximately
Forward-Looking Statements
This press release contains statements concerning our expectations, anticipations and beliefs regarding the future, which constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements, which are based on assumptions that we have made as of the date hereof and are subject to known and unknown risks and uncertainties, often contain words such as "ambition" "anticipate," "believe," "estimate," "expect," "goals" "guidance," "intend," "may," "outlook," "scenario," "should," "would," and "will" and similar references to future periods. Forward-looking statements may include statements regarding: plans and expectations regarding use of transaction proceeds, financial flexibility and optionality, future investments and support, value-creation potential, portfolio focus, other underlying assumptions and outlook considerations, and all other information relating to matters that are not historical facts. These and other forward-looking statements are based on management's current estimates, assumptions and expectations and involve risks and uncertainties that could significantly affect expected results. Actual results could differ materially from those expressed or implied in the forward-looking statements if one or more of the underlying estimates, assumptions or expectations prove to be inaccurate or are unrealized. Factors that could cause Albemarle's actual results to differ materially from the outlook expressed or implied in any forward-looking statement include: breaches of contract; changes in economic and business conditions; changes in trade policies and tariffs; technological change and development; completion of the audit of our annual financial statements; fluctuations in foreign currencies; changes in laws and government regulation; regulatory actions, proceedings, claims or litigation; cyber-security breaches, terrorist attacks, industrial accidents or natural disasters; geopolitical conflicts and political unrest; trade policies and tariffs; changes in inflation or interest rates; volatility in the debt and equity markets; acquisition and divestiture transactions; timing and success of projects; changes in credit ratings; and the other factors detailed from time to time in the reports Albemarle files with the SEC, including those described under "Risk Factors" in Albemarle's most recent Annual Report on Form 10-K and any subsequently filed Quarterly Reports on Form 10-Q, which are filed with the SEC and available on the investor section of Albemarle's website (investors.albemarle.com) and on the SEC's website at www.sec.gov. These forward-looking statements speak only as of the date of this press release. Albemarle assumes no obligation to provide any revisions to any forward-looking statements should circumstances change, except as otherwise required by securities and other applicable laws.
Investor Relations Contact: +1 (980) 308-6194, [email protected]
Media Contact:
View original content to download multimedia:https://www.prnewswire.com/news-releases/albemarle-completes-sale-of-controlling-stake-in-ketjen-to-kps-capital-partners-302701526.html
SOURCE Albemarle Corporation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DeFi Development Corp. plans $20M preferred stock offering
- Metallus CEO Michael Williams to retire; Kris Westbrooks named successor
- Wellchange Holdings closes $7.5M public offering of Class A shares
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Goldman Sachs, Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share